Raconteur Global Resources Capital Structure Change
Max-Bio Biosciences acquired 21,42,857 shares (11.89% stake) in Raconteur Global Resources via preferential allotment. The non-promoter acquirer held no prior stake in the company.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Max-Bio Biosciences acquired 21,42,857 shares (11.89% stake) in Raconteur Global Resources via preferential allotment. The non-promoter acquirer held no prior stake in the company.
Raconteur Global Resources allotted 47,49,999 equity shares at ₹14 each upon conversion of warrants to non-promoter investors. Total issue value is approximately ₹6.65 Crore.
Raconteur Global Resources' board approved calling upon warrant holders for the balance 75% payment on outstanding warrants to facilitate conversion into equity shares.
Raconteur Global Resources Ltd approved a preferential issue of warrants and equity shares, aggregating approximately ₹30 Crore. The board also approved the Director's Report.
Anaaya Management Consultancy acquired 17.85 lakh shares in Raconteur Global via preferential allotment. The acquirer is a non-promoter, classifying this as a Capital Structure Change.
Raconteur Global Resources Ltd received BSE trading approval for 5,564,283 equity shares. This follows a preferential allotment, providing liquidity to the newly issued securities.
Raconteur Global Resources Limited received listing approval from BSE Limited for 5,564,283 equity shares of Rs. 10/- each, issued at a premium of Rs. 4/-. The approval, dated April 23, 2026, pertains to shares issued to non-promoters on a preferential basis. Trading approval is subject to fulfilling further compliance requirements.